<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24">The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in severe adverse impacts worldwide. Available data have shown that patients with COVID-2019 present respiratory symptoms and fever; however, approximately 8.8–60.6% of patients suffer from gastrointestinal symptoms, such as decreased appetite, nausea, vomiting, and diarrhea, as well as possible abnormal liver function [
 <xref ref-type="bibr" rid="CR1">1</xref>–
 <xref ref-type="bibr" rid="CR3">3</xref>]. Although the impacts of SARS-CoV-2 on the gastrointestinal (GI) tract remain unclear, studies of other coronaviruses have revealed a close relation to GI symptoms. We reviewed the coronaviruses that cause GI disorders in mammals or humans to facilitate coping with SARS-CoV-2 infection.
</p>
